Genzyme's Wills Hughes-Wilson switches to Sobi
This article was originally published in Scrip
Wills Hughes-Wilson has joined Swedish Orphan Biovitrum as vice-president of government affairs and policy reporting to Sobi CEO Geoffrey McDonough. Ms Hughes-Wilson previously served at Genzyme since 2005, most recently as vice-president of health/market access policy, Europe. Prior to Genzyme she was executive director of Emerging Biopharmaceutical Enterprises, a specialised group of EFPIA representing biotech companies in Europe.